Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Practice Point
  • Published:

Which clinical variables are associated with lymph node metastases in patients with superficial bladder cancer?

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

References

  1. Sylvester RJ et al. (2002) Intravesical bacillus Calmette–Guerin reduces the risk of progression in patients with superficial bladder cancer: a meta-analysis of the published results of randomized clinical trials. J Urol 168: 1964–1970

    Article  CAS  Google Scholar 

  2. Malavaud B (2004) T1G3 bladder tumours: the case for radical cystectomy. Eur Urol 45: 406–410

    Article  Google Scholar 

  3. Amling CL et al. (1994) Radical cystectomy for stages Ta, Tis and T1 transitional cell carcinoma of the bladder. J Urol 151: 31–35; discussion 35–36

    Article  CAS  Google Scholar 

  4. Malkowicz SB et al. (1990) The role of radical cystectomy in the management of high grade superficial bladder cancer (PA, P1, PIS and P2). J Urol 144: 641–645

    Article  CAS  Google Scholar 

  5. Abdel-Latif M et al. (2004) Nodal involvement in bladder cancer cases treated with radical cystectomy: incidence and prognosis. J Urol 172: 85–89

    Article  Google Scholar 

  6. May M et al. (2004) Survival rates after radical cystectomy according to tumor stage of bladder carcinoma at first presentation. Urol Int 72: 103–111

    Article  Google Scholar 

  7. Solsona E et al. (2004) The optimum timing of radical cystectomy for patients with recurrent high-risk superficial bladder tumour. BJU Int 94: 1258–1262

    Article  Google Scholar 

Download references

Acknowledgements

The synopsis was written by Chloe Harman, Associate Editor, Nature Clinical Practice.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Mohamed Abdel-Latif.

Ethics declarations

Competing interests

The author declares no competing financial interests.

Glossary

OR (ODDS RATIO)

Ratio of odds of an event in intervention group to odds in control group; when <1 for an undesirable outcome, the intervention reduced the risk

CI (CONFIDENCE INTERVAL)

An estimated range of values (based on a given set of sample data) that has a specified probability of containing the value being estimated

T1G3 TUMORS

Superficial bladder tumors with disease confined to the subepithelial connective tissue (T1); cells are poorly differentiated (G3)

BACILLUS CALMETTE–GUÉRIN (BCG)

A live attenuated strain of Mycobacterium tuberculosis that stimulates an immune response against cancer cells within the bladder

Rights and permissions

Reprints and permissions

About this article

Cite this article

Abdel-Latif, M. Which clinical variables are associated with lymph node metastases in patients with superficial bladder cancer?. Nat Rev Urol 2, 214–215 (2005). https://doi.org/10.1038/ncpuro0185

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1038/ncpuro0185

Search

Quick links

Nature Briefing

Sign up for the Nature Briefing newsletter — what matters in science, free to your inbox daily.

Get the most important science stories of the day, free in your inbox. Sign up for Nature Briefing